We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$299M
AUM Growth
+$11.2M
Cap. Flow
-$2.11M
Cap. Flow %
-0.71%
Top 10 Hldgs %
36.39%
Holding
201
New
7
Increased
56
Reduced
101
Closed
2

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$585K
2
GPN icon
Global Payments
GPN
+$492K
3
VTIP icon
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
+$423K
4
AAP icon
Advance Auto Parts
AAP
+$409K
5
IIPR icon
Innovative Industrial Properties
IIPR
+$302K

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.06M
2
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$933K
3
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$514K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$478K
5
AAPL icon
Apple
AAPL
+$431K

Sector Composition

Rank Sector Weight
1 Healthcare 20.46%
2 Technology 16.47%
3 Financials 11.36%
4 Industrials 9.11%
5 Communication Services 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTC icon
26
Intel
INTC
$465B
$2.7M 0.9%
82,724
+4,484
+6% +$127K
NSC icon
27
Norfolk Southern
NSC
$75.5B
$2.66M 0.89%
12,526
– –
RTX icon
28
RTX Corp
RTX
$289B
$2.64M 0.88%
26,980
-149
-0.5% -$14.7K
PG icon
29
Procter & Gamble
PG
$335B
$2.4M 0.8%
16,147
-100
-0.6% -$14.3K
LIN icon
30
Linde
LIN
$222B
$2.36M 0.79%
6,647
-457
-6% -$153K
WMT icon
31
Walmart Inc
WMT
$887B
$2.33M 0.78%
47,478
-540
-1% -$25.6K
DGX icon
32
Quest Diagnostics
DGX
$25.9B
$2.23M 0.75%
15,772
-155
-1% -$22.2K
ANET icon
33
Arista Networks
ANET
$225B
$2.2M 0.74%
52,500
-3,780
-7% -$130K
MGV icon
34
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
$2.18M 0.73%
21,532
+1
+0% +$102
BDX icon
35
Becton Dickinson
BDX
$45.3B
$2.14M 0.71%
8,627
-116
-1% -$28.4K
AMGN icon
36
Amgen
AMGN
$207B
$2.06M 0.69%
8,512
-41
-0.5% -$10.1K
VBR icon
37
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$2.01M 0.67%
12,646
-10
-0.1% -$1.66K
MOAT icon
38
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
$2M 0.67%
27,082
+1,445
+6% +$103K
TECH icon
39
Bio-Techne
TECH
$11.2B
$1.97M 0.66%
26,514
-98
-0.4% -$7.55K
VIG icon
40
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.93M 0.64%
12,513
+475
+4% +$72.8K
UNP icon
41
Union Pacific
UNP
$174B
$1.92M 0.64%
9,545
+45
+0.5% +$9.12K
CNC icon
42
Centene
CNC
$30.8B
$1.78M 0.6%
28,204
+1,350
+5% +$95.8K
CVS icon
43
CVS Health
CVS
$134B
$1.77M 0.59%
23,886
+1,170
+5% +$98.1K
GILD icon
44
Gilead Sciences
GILD
$161B
$1.75M 0.59%
21,131
-498
-2% -$41.2K
WIA
45
Western Asset Inflation-Linked Income Fund
WIA
$184M
$1.74M 0.58%
201,325
-29,996
-13% -$264K
CHRW icon
46
C.H. Robinson
CHRW
$17.8B
$1.73M 0.58%
17,380
-680
-4% -$66.9K
BAB icon
47
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$1.72M 0.58%
64,101
-2,842
-4% -$75.6K
KO icon
48
Coca-Cola
KO
$377B
$1.67M 0.56%
26,894
-2,183
-8% -$132K
VCSH icon
49
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$1.64M 0.55%
21,498
-12,324
-36% -$933K
VRTX icon
50
Vertex Pharmaceuticals
VRTX
$120B
$1.63M 0.55%
5,185
-29
-0.6% -$8.7K
1
2
3 4 5

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Roberts, Glore & Co held 201 positions worth $299M, up 3.9% from $288M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.5%. Roberts, Glore & Co opened 7 new positions and exited 2, leaving the 201-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q1 2023 buy was Global Payments: 4,544 shares worth $478K.
  • Roberts, Glore & Co added most to Charles River Laboratories in Q1 2023, an estimated $585K increase.
  • Roberts, Glore & Co's biggest Q1 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $933K.
  • Roberts, Glore & Co fully exited iShares MSCI EAFE ETF in Q1 2023, selling an estimated $1.06M.
  • Roberts, Glore & Co's ten largest holdings make up 36% of its $299M portfolio in Q1 2023.
  • Roberts, Glore & Co opened 7 new positions and closed 2 in Q1 2023.
  • Roberts, Glore & Co's portfolio value rose 3.9% quarter-over-quarter to $299M.

Based on Roberts, Glore & Co's 13F filing for Q1 2023, filed 8 May 2023.